Indianapolis, IN, United States of America

Arun Srivastava

This inventor holds 4 USPTO granted patents. Top assignees: Research Corporation Technologies, Inc., Advanced Research & Technology Institute, Other. Active years: 1993-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arun Srivastava. Retrieved from https://idiyas.com/inventor/arun-srivastava-w2tokbok

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 4

Forward Citations = 263(Granted Patents)


Company Filing History:


Years Active: 1993-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Arun Srivastava

Introduction

Arun Srivastava is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the area of gene therapy and viral vectors. With a total of 4 patents to his name, his work has had a profound impact on the understanding and application of adeno-associated viruses in gene expression.

Latest Patents

One of Arun Srivastava's latest patents is titled "Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression." This invention identifies a protein known as the D-sequence-binding protein (D-BP), which is phosphorylated at tyrosine residues. The D-BP blocks AAV-mediated transgene expression in infected cells by inhibiting the leading strand viral DNA synthesis. The invention also demonstrates that D-BP is phosphorylated by EGF-R protein tyrosine kinase. Furthermore, methods of increasing transcription and promoting replication of transgenes by exploiting this information are disclosed in this patent. Another significant patent is related to "AAV vectors," which is directed to a recombinant adenovirus vector comprising two inverted terminal repeats (ITRs), each of which includes a D-sequence with specific native nucleotides and potential deletions or substitutions.

Career Highlights

Throughout his career, Arun Srivastava has worked with various organizations, including Research Corporation Technologies, Inc. His expertise in biotechnology and gene therapy has positioned him as a key figure in the development of innovative solutions in this field.

Collaborations

Arun has collaborated with notable professionals in his field, including Selvarangan Ponnazhagan and Xu-Shan Wang. These collaborations have further enhanced his research and contributions to biotechnology.

Conclusion

Arun Srivastava's work exemplifies the innovative spirit of modern inventors. His patents and collaborations have significantly advanced the understanding of gene therapy and viral vectors, making him a prominent figure in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…